0 0 TS Clinic Limited 04994482 false 2024-04-01 2025-03-31 2025-03-31 The principal activity of the company is that of acupuncture services Digita Accounts Production Advanced 6.30.9574.0 true true 04994482 2024-04-01 2025-03-31 04994482 2025-03-31 04994482 core:CurrentFinancialInstruments 2025-03-31 04994482 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 04994482 core:Non-currentFinancialInstruments 2025-03-31 04994482 core:Non-currentFinancialInstruments core:AfterOneYear 2025-03-31 04994482 core:Goodwill 2025-03-31 04994482 core:FurnitureFittingsToolsEquipment 2025-03-31 04994482 bus:SmallEntities 2024-04-01 2025-03-31 04994482 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 04994482 bus:FilletedAccounts 2024-04-01 2025-03-31 04994482 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 04994482 bus:RegisteredOffice 2024-04-01 2025-03-31 04994482 bus:Director1 2024-04-01 2025-03-31 04994482 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 04994482 core:Goodwill 2024-04-01 2025-03-31 04994482 core:FurnitureFittingsToolsEquipment 2024-04-01 2025-03-31 04994482 core:OfficeEquipment 2024-04-01 2025-03-31 04994482 countries:EnglandWales 2024-04-01 2025-03-31 04994482 2024-03-31 04994482 core:Goodwill 2024-03-31 04994482 core:FurnitureFittingsToolsEquipment 2024-03-31 04994482 2023-04-01 2024-03-31 04994482 2024-03-31 04994482 core:CurrentFinancialInstruments 2024-03-31 04994482 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 04994482 core:Non-currentFinancialInstruments 2024-03-31 04994482 core:Non-currentFinancialInstruments core:AfterOneYear 2024-03-31 04994482 core:Non-currentFinancialInstruments core:AfterOneYear core:PreviouslyStatedAmount 2024-03-31 04994482 core:FurnitureFittingsToolsEquipment 2024-03-31 04994482 core:PreviouslyStatedAmount 2024-03-31 xbrli:pure iso4217:GBP

Registration number: 04994482

TS Clinic Limited

Unaudited Financial Statements

for the Year Ended 31 March 2025

Brebners
Chartered Accountants
1 Suffolk Way
Sevenoaks
Kent
TN13 1YL

 

TS Clinic Limited

Statement of Financial Position as at 31 March 2025

Note

2025
£

2024
£

Fixed assets

 

Tangible assets

807

1,027

Current assets

 

Stocks

5

900

900

Debtors

6

23,473

31,819

Cash at bank and in hand

 

28,605

7,757

 

52,978

40,476

Creditors: Amounts falling due within one year

7

(18,721)

(12,872)

Net current assets

 

34,257

27,604

Total assets less current liabilities

 

35,064

28,631

Creditors: Amounts falling due after more than one year

7

(1,792)

(6,732)

Net assets

 

33,272

21,899

Capital and reserves

 

Called up share capital

2

2

Retained earnings

33,270

21,897

Shareholders' funds

 

33,272

21,899

 

TS Clinic Limited

Statement of Financial Position as at 31 March 2025

For the financial year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and FRS 102 ‘The Financial Reporting Standard Applicable in the UK and Republic of Ireland’.

The director of TS Clinic Limited has elected not to include a copy of the profit and loss account within the financial statements, in accordance with the special provisions relating to companies subject to the small companies regime within the Companies Act 2006, s444.

Approved and authorised by the director on 11 December 2025
 

.........................................

Mr T Simou

Director

Company registration number: 04994482

 

TS Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
55 Tweedy Road
Bromley
Kent
BR1 3NH
 

The principal activity of the company is that of acupuncture services

2

Accounting policies

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' Section 1A and the Companies Act 2006.

Basis of preparation

These financial statements have been prepared using the historical cost convention except any items disclosed in the accounting policies as being shown at fair value and are presented in sterling, which is the functional currency of the entity.

Summary of significant accounting policies

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Going concern

The company made a profit for the year ended 31 March 2025 and had net assets of £33,272 at that date. The company has continued to trade profitably since 31 March 2025.

Based on the above, the director has a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Accordingly, the going concern basis has been adopted in preparing the financial statements.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the provision of services in the ordinary course of the company's activities. Turnover is shown net of sales, returns, rebates and discounts.

The company recognises revenue from acupuncture services on the date the services are provided.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a charge attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

 

TS Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Office equipment

20% Straight Line

Goodwill

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date. Goodwill is amortised over its useful life, which shall not exceed ten years if a reliable estimate of the useful life cannot be made.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class

Amortisation method and rate

Goodwill

14 years

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

 

TS Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the income statement over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3

Staff numbers

The average number of persons employed by the company during the year, was 0 (2024 - 0).

4

Intangible assets

Goodwill
 £

Total
£

Cost or valuation

At 1 April 2024

160,000

160,000

At 31 March 2025

160,000

160,000

Amortisation

At 1 April 2024

160,000

160,000

At 31 March 2025

160,000

160,000

Carrying amount

At 31 March 2025

-

-

 

TS Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Tangible assets

Furniture, fittings and equipment
 £

Total
£

Cost or valuation

At 1 April 2024

5,168

5,168

At 31 March 2025

5,168

5,168

Depreciation

At 1 April 2024

4,141

4,141

Charge for the year

220

220

At 31 March 2025

4,361

4,361

Carrying amount

At 31 March 2025

807

807

At 31 March 2024

1,027

1,027

5

Stocks

2025
£

2024
£

Stock

900

900

6

Debtors

2025
£

2024
£

Other debtors

23,473

31,819

23,473

31,819

7

Creditors

Creditors: amounts falling due within one year

Note

2025
£

2024
£

Loans and borrowings

8

4,823

4,705

Other creditors and accruals

 

1,800

1,800

Taxation and social security

 

12,098

6,367

 

18,721

12,872

 

TS Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Creditors: amounts falling due after more than one year

Note

2025
£

2024
£

Loans and borrowings

8

1,792

6,732

8

Loans and borrowings

Current loans and borrowings

2025
£

2024
£

Bank loan

4,823

4,705

Non-current loans and borrowings

2025
£

2024
£

Bank loan

1,792

6,732

9

Transactions with directors

At 31 March 2025 an amount of £9,901 (2024: £18,139) was due from the directors. During the year advances of £48,866 and repayments of £57,322 were made. Interest of £108 (2024: £399) is payable to the company at 2.25% p.a. There are no agreed terms in place.